Winfrey opened up about her decision to use a medication to help her lose weight in an interview with People. Her new TV ...

Mounjaro, like other GLP-1 drugs, carries potential side effects, including nausea, vomiting, dehydration, and hypoglycaemia ...

The Biden administration released another list of prescriptions drugs that would be subject to price controls. The price controls for the selected drugs will become effective in 2027.

Obesity is a significant global health challenge, linked to an increased risk of conditions like diabetes, heart disease, and ...

A letter from several Democratic Senators urged Trump to use his deal-making skills to “flat out reject any request to end ...

Medicare seeks to negotiate prices on 15 drugs, including Novo Nordisk's (NVO) GLP-1 weight-loss drugs Ozempic and Wegovy, in ...

Medicare has announced 15 new drugs up for price negotiations, set to begin in the next several months with top drugmakers, ...

including Pfizer, Novartis, and Eli Lilly, are expanding their R&D efforts to seek more effective remedies to the obesity issue. Despite this rapid growth, GLP-1 weight loss medications present ...

On Friday, the U.S. Department of Health and Human Services (HHS) unveiled the selection of 15 additional drugs covered under ...

Novo Nordisk's Ozempic and Wegovy are among 15 drugs targeted for Medicare price negotiations in 2027. The U.S. aims to cut ...